Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.
It is common for patients with idiopathic Parkinson's disease to develop levodopa-induced dyskinesia. This report provides what we believe is the first videotape presentation of levodopa-induced dyskinesia in a patient with progressive supranuclear palsy. To our knowledge, there is only one previous report of an autopsy-proven case of this kind.
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D046508:Culture Techniques; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000209:etiology*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D016874:Neurofibrillary Tangles / Q000473:pathology; D013494:Supranuclear Palsy, Progressive / Q000188:drug therapy* / Q000473:pathology
D000978:Antiparkinson Agents; D007980:Levodopa